Irlanda - inglese - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - latanoprost, timolol maleate - eye drops solution - 50mcg/ml + 5 mg/ml - beta blocking agents

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - triamcinolone acetonide - nasal spray, suspension - 55 microgram(s)/dose - corticosteroids; triamcinolone

Irlanda - inglese - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - aluminium oxide hydrated, magnesium hydroxide - oral suspension - 460/400 milligram - combinations - for the relief of the symptoms of dyspepsia

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Australia - inglese - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - aflibercept -

Unione Europea - inglese - EMA (European Medicines Agency)

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.